Biotech Co. NanoString Gets OK On Ch. 11 Wind Down Plan
NanoString Technologies Inc., a Seattle-based maker of gene analysis technology, can use proceeds from the $393 million sale of its business to repay nearly all creditors in full after a Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article